Skip to main content
SpringerLink
Log in

Response to “Temporal Muscle Atrophy: An Independent Prognosis Biomarker or Secondary to Disuse?”

  • Response to Letter To The Editor
  • Published:
Neurocritical Care Aims and scope Submit manuscript

A Letters to the editor to this article was published on 31 August 2023

The Original work to this article was published on 12 June 2023

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. De Barros OL, Rabelo NN, Figueiredo EG. Temporal muscle atrophy: an independent prognosis biomarker or secondary to disuse? Neurocrit Care. 2023. https://doi.org/10.1007/s12028-023-01834-x.

    Article  Google Scholar 

  2. Berg HE, Larsson L, Tesch PA. Lower limb skeletal muscle function after 6 wk of bed rest. J Appl Physiol. 1997;82:182–8.

    Article  CAS  PubMed  Google Scholar 

  3. Fink H, Helming M, Unterbuchner C, et al. Systemic inflammatory response syndrome increases immobility-induced neuromuscular weakness. Crit Care Med. 2008;36:910–6.

    Article  PubMed  Google Scholar 

  4. Jolley SE, Bunnell AE, Hough CL. ICU-acquired weakness. Chest. 2016;150:1129–40.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Batt J, dos Santos CC, Cameron JI, Herridge MS. Intensive care unit-acquired weakness: clinical phenotypes and molecular mechanisms. Am J Respir Crit Care Med. 2013;187:238–46.

    Article  PubMed  Google Scholar 

  6. Puthucheary ZA, Rawal J, McPhail M, et al. Acute skeletal muscle wasting in critical illness. JAMA. 2013;310:1591–600.

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

This work received no funding.

Author information

Authors and Affiliations

  1. Neurological Intensive Care Unit, Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria

    Mario Kofler & Raimund Helbok

  2. Department of Anesthesiology and Intensive Care Medicine, Medical University of Innsbruck, Innsbruck, Austria

    Mario Kofler

  3. Department of Neurology, Neuromed Campus and Med Campus, Kepler Universitätsklinikum GmbH, Johannes Kepler University, Linz, Austria

    Raimund Helbok

Authors
  1. Mario Kofler
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Raimund Helbok
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Raimund Helbok.

Ethics declarations

Conflicts of Interest

The authors confirm that the article was made without any commercial or financial relationships that characterize a potential conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is related to the original article available at https://link.springer.com/article/10.1007/s12028-023-01751-z. This article is a response to the Letter to the Editor available at https://link.springer.com/article/10.1007/s12028-023-01834-x.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kofler, M., Helbok, R. Response to “Temporal Muscle Atrophy: An Independent Prognosis Biomarker or Secondary to Disuse?”. Neurocrit Care 39, 551–552 (2023). https://doi.org/10.1007/s12028-023-01835-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12028-023-01835-w

Search

Navigation